Bravelle 75 IU Injection | Order Bravelle 75 IU Injection Online at Truemeds

About Bravelle 75 Iu Injection 1

Bravelle 75 Iu Injection 1 is a hormonal medicine used to treat female infertility. It is prescribed for women who have difficulty ovulating due to polycystic ovarian disease (PCOD) or who are undergoing assisted reproductive technologies (ART) such as in vitro fertilisation (IVF).

It contains follicle-stimulating hormone (FSH), which stimulates the growth and development of egg follicles in the ovaries. This injection is administered by or under the guidance of a fertility specialist or healthcare provider. Dosage and monitoring schedules are tailored individually using blood hormone tests and ultrasound scans.

Following your fertility specialist's guidelines regarding treatment timing, lifestyle recommendations, and monitoring appointments is important throughout the treatment cycle.

Before receiving this medicine, inform your doctor if you have thyroid disorders, adrenal gland problems, ovarian cysts, unexplained vaginal bleeding, or a history of blood clots. It is not intended for use during pregnancy once pregnancy is confirmed or during breastfeeding. Report any severe pelvic pain, rapid weight gain, or abdominal swelling to your healthcare team promptly.

Frequently Asked Questions (FAQs)

What is Bravelle 75 Iu Injection 1 used for?

This injection is used to induce ovulation in infertile women, and sustain pregnancy during the early stages.

Why is Bravelle 75 Iu Injection 1 given in early pregnancy?

This injection may be used in early pregnancy to support the luteal phase and sustain pregnancy.

Does Bravelle 75 Iu Injection 1 increase the chances of pregnancy?

Yes, this injection can enhance the chances of pregnancy by inducing ovulation in infertile women and supporting early pregnancy.

When is the best time for Bravelle 75 Iu Injection 1?

A doctor determines the timing of this injection administration based on individual treatment plans.

At what specific time interval following the administration of Bravelle 75 Iu Injection 1 does the egg release occur?

The release of the egg after this injection typically occurs within a specific timeframe guided by the treatment plan determined by a doctor.

References

Andrea Cocci, Gianmartin Cito and others. Effectiveness of highly purified urofollitropin treatment in patients with idiopathic azoospermia before testicular sperm extraction. Urologia Journals. SAGE Journals. [Revised in July 2017]. https://journals.sagepub.com/doi/10.5301/uj.5000253
Bharat Serums and Vaccines Ltd. Foligraf 75 I.U./150 I.U. https://bsvgroup.com/assets/pdf/products/Foligraf.pdf
Ferring Pharmaceuticals Inc. Bravelle (Urofollitropin for Injection). U.S. Food and Drug Administration. [Revised in February 2014]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021289s019lbl.pdf

Disclaimer

We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers. However, it should, by no means, be considered a substitute for prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact we detest any form of self medication without expert advice. The sole purpose of the information on our portal is to educate our consumers, which helps improve the communication between a doctor and a patient. The information by no means is complete in its entirety and should not be used to diagnose or treat any medical condition. No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately.